Pathstone Family Office’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $47.9K | Buy |
+10,519
| New | +$47.9K | ﹤0.01% | 1624 |
|
|
2019
Q1 | – | Sell |
-335
| Closed | -$3K | – | 919 |
|
|
2018
Q4 | $3K | Hold |
335
| – | – | ﹤0.01% | 418 |
|
|
2018
Q3 | $4K | Buy |
335
+200
| +148% | +$2.39K | ﹤0.01% | 190 |
|
|
2018
Q2 | $2K | Sell |
135
-200
| -60% | -$2.96K | ﹤0.01% | 146 |
|
|
2018
Q1 | $5K | Hold |
335
| – | – | ﹤0.01% | 285 |
|
|
2017
Q4 | $3K | Hold |
335
| – | – | ﹤0.01% | 122 |
|
|
2017
Q3 | $3K | Buy |
+335
| New | +$3K | ﹤0.01% | 159 |
|